A.J. Breugom - Concepedia

Author

A.J. Breugom

Leiden University Medical Center

Also Known As

A. Breugom, A. J. Breugom, A.J. Breugom, Anne J Breugom, Anne J. Breugom, Breugom, A.J.

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Reinier de Graaf Hospital Haga Hospital Netherlands Comprehensive Cancer Organisation Radboud University Nijmegen

About

A.J. Breugom is an author at Leiden University Medical Center specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	566
2	Public Health	1	1	19
3	Epidemiology	1	1	19
4	Family Medicine	1	1	50
5	Gastroenterology	1	1	43

A.J. Breugom

Publications

679

Citations

H-Index

Page 1

	Year	Citations
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial A.J. Breugom, W. van Gijn, E.W. Muller, Annals of Oncology Rectal Cancer PatientsSurgical OncologyRadiation TherapyGastrointestinal OncologyColorectal Surgery	2014	383
Differences between colon and rectal cancer in complications, short-term survival and recurrences Max P.L. van der Sijp, Esther Bastiaannet, Wilma E. Mesker, International Journal of Colorectal Disease	2016	113
Comprehensive multidisciplinary care program for elderly colorectal cancer patients: “From prehabilitation to independence” Esteban T.D. Souwer, Esther Bastiaannet, S. de Bruijn, European Journal of Surgical Oncology Family MedicineGeriatric OncologyPrehabilitationSurgical OncologyHealth Policy	2018	50
Association Between the Most Frequent Complications After Surgery for Stage I–III Colon Cancer and Short-Term Survival, Long-Term Survival, and Recurrences A.J. Breugom, D. T. van Dongen, Esther Bastiaannet, Annals of Surgical Oncology Surgical OncologyGastrointestinal OncologyColorectal SurgeryCancer RecurrenceMedicine	2016	43
Adjuvant chemotherapy and relative survival of patients with stage II colon cancer – A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania A.J. Breugom, Esther Bastiaannet, Petra G. Boelens, European Journal of Cancer Gastrointestinal OncologyMedicineRelative SurvivalCancer ManagementAdjuvant Chemotherapy	2016	32
Decrease in 30-day and one-year mortality over time in patients aged ≥75 years with stage I–III colon cancer: A population-based study A.J. Breugom, Esther Bastiaannet, Jan Willem T. Dekker, European Journal of Surgical Oncology One-year MortalityEpidemiologyPopulation-based StudyCancer EpidemiologyGastrointestinal Oncology	2018	19
The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemoradiation followed by TME-surgery: The PROCTOR/SCRIPT study A.J. Breugom, C.B.M. van den Broek, W. van Gijn, Data Archiving and Networked Services (DANS) Rectal Cancer PatientsSurgical OncologyRadiation TherapyProctor/script StudyMedicine	2013	17
Oncologic treatment strategies and relative survival of patients with stage I–III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania A.J. Breugom, Esther Bastiaannet, Petra G. Boelens, European Journal of Surgical Oncology Surgical OncologyGastrointestinal OncologyMedicineCancer RecurrenceRelative Survival	2018	12
Effect of preoperative treatment strategies on the outcome of patients with clinical T3, non-metastasized rectal cancer: A comparison between Dutch and Canadian expert centers A.J. Breugom, T.A. Vermeer, C.B.M. van den Broek, European Journal of Surgical Oncology Canadian Expert CentersSurgical OncologyGastrointestinal OncologyColorectal SurgeryMedicine	2015	10

Page 1